Detalhe da pesquisa
1.
Histopathological diagnosis of cutaneous melanocytic lesions: blinded and nonblinded second opinions offer similar improvement in diagnostic accuracy.
Clin Exp Dermatol
; 47(9): 1658-1665, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426450
2.
Combining biomarkers by maximizing the true positive rate for a fixed false positive rate.
Biom J
; 63(6): 1223-1240, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33871887
3.
Statistical inference for net benefit measures in biomarker validation studies.
Biometrics
; 76(3): 843-852, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732971
4.
Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
J Am Acad Dermatol
; 79(1): 52-59.e5, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29524584
5.
Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
Ann Surg Oncol
; 24(5): 1234-1241, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27913946
6.
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective.
Ann Intern Med
; 164(10): 649-55, 2016 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26999810
7.
Early-Phase Studies of Biomarkers: What Target Sensitivity and Specificity Values Might Confer Clinical Utility?
Clin Chem
; 62(5): 737-42, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27001493
8.
Designing a study to evaluate the benefit of a biomarker for selecting patient treatment.
Stat Med
; 34(27): 3503-15, 2015 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26112650
9.
Diagnostic concordance among pathologists interpreting breast biopsy specimens.
JAMA
; 313(11): 1122-32, 2015 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25781441
10.
Net reclassification indices for evaluating risk prediction instruments: a critical review.
Epidemiology
; 25(1): 114-21, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24240655
11.
Adopting nested case-control quota sampling designs for the evaluation of risk markers.
Lifetime Data Anal
; 19(4): 568-88, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23807695
12.
Further insight into the incremental value of new markers: the interpretation of performance measures and the importance of clinical context.
Am J Epidemiol
; 176(6): 482-7, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22875756
13.
Measuring the performance of markers for guiding treatment decisions.
Ann Intern Med
; 154(4): 253-9, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21320940
14.
Problems with risk reclassification methods for evaluating prediction models.
Am J Epidemiol
; 173(11): 1327-35, 2011 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21555714
15.
Joint modeling, covariate adjustment, and interaction: contrasting notions in risk prediction models and risk prediction performance.
Epidemiology
; 22(6): 805-12, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21968770
16.
Discordant Interpretations of Breast Biopsy Specimens by Pathologists--Reply.
JAMA
; 314(1): 83-4, 2015 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26151274
17.
Adding Rigor to Biomarker Evaluations-EDRN Experience.
Cancer Epidemiol Biomarkers Prev
; 29(12): 2575-2582, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172885
18.
Assessing the value of risk predictions by using risk stratification tables.
Ann Intern Med
; 149(10): 751-60, 2008 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19017593
19.
Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions.
JAMA Netw Open
; 2(10): e1912597, 2019 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31603483
20.
Adjusting for covariates in studies of diagnostic, screening, or prognostic markers: an old concept in a new setting.
Am J Epidemiol
; 168(1): 89-97, 2008 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18477651